Mobile

Chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases The CHARISMA randomized multicenter clinical trial Chemotherapie gevol...

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-004952-39

Chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases The CHARISMA randomized multicenter clinical trial Chemotherapie gevolgd door chirurgie versus chirurgie alleen in hoog-risico patienten met resectabele colorectale levermetastasen De CHARISMA gerandomiseerde multicenter trial

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of the study is to compare the efficacy, as assessed by overall survival (OS), of surgery and neo-adjuvant chemotherapy to surgery alone in patients with liver metastases of colorectal cancer and a high clinical risk score. Doel van de studie is om de effectiviteit van chirurgie met neo-adjuvante chemotherapie te vergelijken met chirurgie alleen in patienten met colorectale levermetastasen en een hoge risico score.

Critère d'inclusion

  • Colorectal liver metastases,Colorectale levermetastasen

Liens